[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 4, 1991

Pharmaceutical Sponsorship, CME, and the Prurient Desires of Registrants-Reply

Author Affiliations

American Medical Association Chicago, Ill

American Medical Association Chicago, Ill

JAMA. 1991;266(21):2986. doi:10.1001/jama.1991.03470210054027

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

In Reply.  —The ACCME guidelines for commercial support of CME and the AMA guidelines for physician relationships with industry apply regardless of whether a CME activity is designated AMA PRA category 1, AMA PRA category 2, or whether there is no designation whatsoever, meaning that a physician determines individually whether the activity meets an educational need.If an accredited sponsor finds that it cannot sponsor a pharmaceutical company-related activity for AMA PRA category 1 credit, it must also find that it cannot sponsor that activity for AMA PRA category 2 credit. In that circumstance, the pharmaceutical company has a choice of changing the activity to meet a prospective sponsor's concerns or of providing the activity without accredited sponsorship. The hope is, certainly, that pharmaceutical firms will find ways of participating in CME that meet the guidelines. Many firms have, in fact, indicated that this is their intention.If pharmaceutical firms

×